MARCO ISLAND, Fla. — Two-year follow-up of the ROMEO study showed efficacy of the Omni surgical system in reducing IOP and medication use over the long term in patients with primary open-angle glaucoma.
The 2-year data were presented in a poster by Anita Campbell, MD, and colleagues at the Women in Ophthalmology Summer Symposium.
ROMEO was the first multicenter study evaluating circumferential canaloplasty plus trabeculotomy using the Omni surgical system (Sight Sciences) and provided the basis for FDA clearance. The 2-year extension included 65% of ROMEO subjects treated in seven of the